# MINERALYS THERAPEUTICS INC (MLYS)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MLYS/

- Reporting holders: 4
- Reported value: $44.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $23.2K | 925 | 0.0% | 9 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $14.9K | 593 | 0.0% | 12 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $5.6K | 224 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1.1K | 45 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $44.9K |
| Q2 2026 | 229 | $2.9B |
| Q1 2026 | 216 | $2.7B |
| Q4 2025 | 226 | $3.5B |
| Q3 2025 | 194 | $3.0B |
| Q2 2025 | 167 | $890.0M |
| Q1 2025 | 152 | $982.4M |
| Q4 2024 | 109 | $572.3M |
| Q3 2024 | 105 | $540.6M |
| Q2 2024 | 94 | $523.3M |
| Q1 2024 | 92 | $554.5M |
| Q4 2023 | 87 | $303.3M |